Univest Securities, LLC said a $9 million registered direct offering for its client China SXT Pharmaceuticals Inc. has officially closed. The transaction was announced from New York on July 24, 2026, with the company identified under the Nasdaq ticker SXTC.
The update centers on the completion of the financing, which is a registered direct offering structure commonly used by public companies to raise capital from investors. Based on the available release, Univest acted in connection with the deal for China SXT Pharmaceuticals.
Univest described itself as a New York-based full-service investment bank and securities broker-dealer, and noted that it is a member of FINRA and SIPC. The announcement highlights the firm’s role in helping bring the transaction to a close for its client.
While the excerpt does not provide the full terms beyond the $9 million size, the closing marks a completed capital markets event for China SXT Pharmaceuticals. For investors following SXTC, the news signals that the company has finalized this financing transaction.
